Skip to main content

Vascular Access Complication

1
Pipeline Programs
6
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
1 program
1
P-MaxPhase 41 trial
Active Trials
NCT01763801Completed326Est. Mar 2012
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Arterial Line PlacementN/A1 trial
Active Trials
NCT03326739Completed40Est. Dec 2019
Bactiguard
BactiguardSweden - Tullinge
1 program
BIP CVCN/A1 trial
Active Trials
NCT03976557Terminated19Est. Dec 2019
Abbott
AbbottABBOTT PARK, IL
1 program
Manual compressionN/A1 trial
Active Trials
NCT01911403Terminated123Est. Sep 2014
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
dynamicN/A1 trial
Active Trials
NCT03656978Completed134Est. Mar 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpP-Max
BactiguardBIP CVC
UNION therapeuticsdynamic
Temple TherapeuticsArterial Line Placement
AbbottManual compression

Clinical Trials (5)

Total enrollment: 642 patients across 5 trials

NCT01763801BiocorpP-Max

Optimization of EKG Method for Long Term Central Venous Catheter Tip Placement

Start: Jul 2011Est. completion: Mar 2012326 patients
Phase 4Completed
NCT03976557BactiguardBIP CVC

BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden

Start: Apr 2019Est. completion: Dec 201919 patients
N/ATerminated
NCT03656978UNION therapeuticsdynamic

Ultrasound-Guided Vascular Puncture and Catheterization

Start: Jun 2017Est. completion: Mar 2019134 patients
N/ACompleted
NCT03326739Temple TherapeuticsArterial Line Placement

Ultrasound Guided Versus Landmark Guided Arterial Line Placement by Emergency Medicine Interns

Start: Jan 2017Est. completion: Dec 201940 patients
N/ACompleted
NCT01911403AbbottManual compression

AGIR Study: Angio-Seal in Interventional Radiology

Start: Dec 2010Est. completion: Sep 2014123 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.